|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/19 | |
| A61K 45/06 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3006023 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15192647.4 |
| Europos patento paraiškos padavimo data | 2010-01-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 145931 P | 2009-01-20 | US |
| (72) |
Tsai, Guochuan Emil, US
|
| (73) |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,
1124 West Carson Street, Torrance, CA 90250-2064,
US
|
| (54) | SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL |
| SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL |